Intelligence · Clinical Development
Pipeline search results
Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Fasinumab
Regeneron UK Limited
Healthy Volunteers
1 trial -
Febuxostat XR
Takeda
Healthy Volunteers
1 trial -
Febuxostat XR 80 mg Capsule F1
Takeda
Healthy Volunteers
1 trial -
Ferric Carboxymaltose Injection
The First People's Hospital of Lianyungang
Healthy Adult
1 trial -
Fexofenadine 180 mg tablets
Teva Pharma GmbH
Healthy
2 trials -
Finasteride 5 mg tablets
Teva Pharma GmbH
Healthy
2 trials -
Firibastat
Quantum Biopharma
Healthy Males
1 trial -
Fluoxetine Hydrochloride
Teva Pharma GmbH
Healthy
2 trials -
Four naloxone nasal spray doses (1 every 2.5 min)
BRIGHT MINDS BIOSCIENCES INC.
Healthy Subjects
1 trial -
Fucoidan (extract of Laminaria japonica)
Takeda
Healthy Volunteers
1 trial -
G23-00
Lacuna Pharma Pty Ltd
healthy volunteer
1 trial -
GC4419
Galera Therapeutics
Healthy Volunteers
1 trial -
GC4419 IV
Galera Therapeutics
Healthy Volunteers
1 trial -
GC4702 dry powder
Galera Therapeutics
Healthy Volunteer
1 trial -
GC4711 30 mg IV
Galera Therapeutics
Healthy Volunteers
1 trial -
GC4711 30mg
Galera Therapeutics
Healthy
1 trial -
GC4711 Oral Capsule G-101
Galera Therapeutics
Healthy Volunteers
1 trial -
GFC-BEMD-01-NXP/23
NEURAXPHARM AUSTRALIA PTY LIMITED
Study performed on healthy volunteers.
1 trial -
GLA-AF
Lxo Ireland Designated Activity Company
Healthy Volunteers
1 trial -
GLPG0187
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG0187 prodrug
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG0259
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG0259 fumarate
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG0259 solution
Lakefront Biotherapeutics NV
Healthy
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.